Michael Lichtenauer

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Topics

Pulmonary Artery

Systematic Review

Pulmonary Hypertension

Top Venues

Journal of clinical medicine

Journal of personalized medicine

Scientific reports

Journal of cardiovascular development and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Elke Boxhammer, Moritz Mirna, Laura Bäz, Nina Bacher, Albert Topf, Brigitte Sipos, Marcus Franz, Daniel Kretzschmar, Uta C Hoppe, Alexander Lauten, Michael Lichtenauer
Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR? Life (Basel, Switzerland) 12 (3) (2022)
Elke Boxhammer, Alexander E Berezin, Vera Paar, Nina Bacher, Albert Topf, Sergii Pavlov, Uta C Hoppe, Michael Lichtenauer
Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of personalized medicine 12 (4) (2022)
Albert Topf, Moritz Mirna, Nina Bacher, Vera Paar, Christoph Edlinger, Lukas J Motloch, Sarah Gharibeh, Marwin Bannehr, Uta C Hoppe, Michael Lichtenauer
The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events. Journal of cardiovascular development and disease 8 (10) (2021)
Peter Jirak, Bernhard Wernly, Michael Lichtenauer, Vera Paar, Marcus Franz, Thorben Knost, Thaer Abusamrah, Malte Kelm, Johanna M Muessig, Nana-Yaw Bimpong-Buta, Christian Jung
Dynamic Changes of Heart Failure Biomarkers in Response to Parabolic Flight. International journal of molecular sciences 21 (10) (2020)
Robert Schönbauer, Michael Lichtenauer, Vera Paar, Michael Emich, Monika Fritzer-Szekeres, Christoph Schukro, Jeanette Strametz-Juranek, Michael Sponder
Regular Training Increases sTWEAK and Its Decoy Receptor sCD163-Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect? Journal of clinical medicine 9 (6) (2020)
Moritz Mirna, Albert Topf, Bernhard Wernly, Richard Rezar, Vera Paar, Christian Jung, Hermann Salmhofer, Kristen Kopp, Uta C Hoppe, P Christian Schulze, Daniel Kretzschmar, Markus P Schneider, Ulla T Schultheiß, Claudia Sommerer, Katharina Paul, Gunter Wolf, Michael Lichtenauer, Martin Busch
Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study. Journal of clinical medicine 9 (3) (2020)
Peter Jirak, Rudin Pistulli, Michael Lichtenauer, Bernhard Wernly, Vera Paar, Lukas J Motloch, Richard Rezar, Christian Jung, Uta C Hoppe, P Christian Schulze, Daniel Kretzschmar, Rüdiger C Braun-Dullaeus, Tarek Bekfani
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls. Journal of clinical medicine 9 (4) (2020)
Peter Jirak, Bernhard Wernly, Michael Lichtenauer, Marcus Franz, Thorben Knost, Thaer Abusamrah, Malte Kelm, Nana-Yaw Bimpong-Buta, Christian Jung
Next-generation sequencing analysis of circulating micro-RNA expression in response to parabolic flight as a spaceflight analogue. NPJ microgravity 6 (1) (2020)
Peter Jirak, Moritz Mirna, Bernhard Wernly, Vera Paar, Uta C Hoppe, Michael Lichtenauer
Assessment of Cardiac Remodeling-A Chance for Novel Cardiac Biomarkers? Journal of clinical medicine 9 (7) (2020)
Bernhard Wernly, Georg Fuernau, Maryna Masyuk, Johanna Maria Muessig, Susanne Pfeiler, Raphael Romano Bruno, Steffen Desch, Phillip Muench, Michael Lichtenauer, Malte Kelm, Volker Adams, Holger Thiele, Ingo Eitel, Christian Jung
Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury. Scientific reports 9 (1) (2019)